Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07449728 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression

Study acronym: LACROSS-VVP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Technically successful laser crossectomy will reduce the risk of reflux recurrence at the sapheno-femoral junction without increasing the risk of endovenous heat-induced thrombosis, which may positively impact the likelihood of ultrasound- or clinical-recurrence of varicose veins. Similar technical efficacy is expected for laser crossectomy at 1940 nm and 1470 nm. A possible advantage of the 1940 nm wavelength in terms of postoperative pain intensity and the risk of adverse events cannot be ruled out.
Trial Details
NCT Number NCT07449728
Lead Sponsor Pirogov Russian National Research Medical University
Conditions
(from sponsor)		 Varicose Veins, Chronic Venous Insufficiency
Related terms Gastroesophageal Reflux, Recurrence, Varicose Veins
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov